- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Orchestra BioMed (OBIO)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 42.01 mm | 42.01 mm | 42.01 mm | 42.01 mm | 42.01 mm | 42.01 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 6.77 mm | 6.27 mm | 4.85 mm | 5.02 mm |
| Cash used (since last report) | n/a | n/a | 15.00 mm | 13.89 mm | 10.74 mm | 11.12 mm |
| Cash remaining | n/a | n/a | 27.01 mm | 28.12 mm | 31.27 mm | 30.89 mm |
| Runway (months of cash) | n/a | n/a | 4.0 | 4.5 | 6.4 | 6.2 |
| 13F holders | Current |
|---|---|
| Total holders | 54 |
| Opened positions | 9 |
| Closed positions | 5 |
| Increased positions | 26 |
| Reduced positions | 7 |
| 13F shares | Current |
|---|---|
| Total value | 74.62 bn |
| Total shares | 26.76 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| RTW Investments | 8.21 mm | $32.82 bn |
| MDT Medtronic | 5.87 mm | $32.81 mm |
| Perceptive Advisors | 4.59 mm | $18.37 bn |
| BlackRock | 1.98 mm | $7.92 bn |
| HSAC 2 | 1.71 mm | $10.71 mm |
| Vanguard | 1.32 mm | $5.27 bn |
| Geode Capital Management | 572.44 k | $2.29 bn |
| T. Rowe Price | 487.17 k | $1.95 mm |
| STT State Street | 447.71 k | $1.79 bn |
| Boxer Capital Management | 238.19 k | $952.77 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 25 Nov 25 | Taylor Andrew Lawrence | Common Stock, par value $0.0001 per share | Payment of exercise | Dispose F | No | No | 5.35 | 3,071 | 16.43 k | 463,615 |
| 25 Nov 25 | Sherman Darren | Common Stock, par value $0.0001 per share | Payment of exercise | Dispose F | No | No | 5.35 | 40,340 | 215.82 k | 846,157 |
| 14 Nov 25 | Hochman David P | Common Stock, par value $0.0001 per share ("Common Stock") | Buy | Acquire P | No | No | 4.07 | 5,000 | 20.35 k | 612,822 |
| 13 Nov 25 | Hochman David P | Common Stock | Payment of exercise | Dispose F | Yes | No | 4.18 | 3,283 | 13.72 k | 442,765 |
| 13 Nov 25 | Hochman David P | Common Stock, par value $0.0001 per share ("Common Stock") | Payment of exercise | Dispose F | No | No | 4.18 | 3,283 | 13.72 k | 607,822 |
| 19 Sep 25 | Aryeh Jason | Common Stock, par value $0.0001 per share | Buy | Acquire P | No | No | 2.45 | 1,000 | 2.45 k | 108,482 |